The Wuhan institute said in its statement that it made the patent application out of national interest, and won’t exercise its patent rights if foreign pharmaceutical firms work together with China to curb the contagion.
When Gilead wants to sell the drug to other countries for fighting new coronavirus, it will have to negotiate with China as the country which owns the patent for that specific purpose.”
When Gilead wants to sell the drug to other countries for fighting new coronavirus, it will have to negotiate with China as the country which owns the patent for that specific purpose.”
